Cyxone Future Growth

Future criteria checks 0/6

Cyxone's revenue and earnings are forecast to decline at 122.2% and 20.2% per annum respectively while EPS is expected to decline by 6.9% per annum.

Key information

-20.2%

Earnings growth rate

-6.9%

EPS growth rate

Biotechs earnings growth45.3%
Revenue growth rate-122.2%
Future return on equityn/a
Analyst coverage

Low

Last updated27 Feb 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

OM:CYXO BTA - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-39-37-371
12/31/2025N/A-38-35-351
12/31/2024N/A-28-26-261
3/31/20245-22-25-18N/A
12/31/20235-23-26-19N/A
9/30/20236-17-32-18N/A
6/30/20236-23-33-21N/A
3/31/20238-31-46-36N/A
12/31/20226-42-49-41N/A
9/30/2022N/A-54-51-50N/A
6/30/2022N/A-54-55-54N/A
3/31/2022N/A-53-45-44N/A
12/31/2021N/A-45-44-43N/A
9/30/2021N/A-43-43-43N/A
6/30/2021N/A-45-39-44N/A
3/31/2021N/A-47-45-45N/A
12/31/2020N/A-49-45-45N/A
9/30/2020N/A-46-43-43N/A
6/30/2020N/A-46-46-41N/A
3/31/2020N/A-39-36-36N/A
12/31/2019N/A-35-35-35N/A
9/30/2019N/A-47-57-43N/A
6/30/2019N/A-39-49-36N/A
3/31/2019N/A-36-49-35N/A
12/31/2018N/A-32-43-30N/A
9/30/2018N/A-14-19-13N/A
6/30/2018N/A-11-16-10N/A
3/31/2018N/A-10-13-7N/A
12/31/2017N/A-9N/A-5N/A
9/30/20170-7N/A-6N/A
6/30/2017N/A-7N/A-8N/A
3/31/2017N/A-5N/A-5N/A
12/31/2016N/A-4N/A-4N/A
12/31/201500N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CYXO BTA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CYXO BTA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CYXO BTA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CYXO BTA is forecast to have no revenue next year.

High Growth Revenue: CYXO BTA is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CYXO BTA's Return on Equity is forecast to be high in 3 years time


Discover growth companies